Literature DB >> 28437058

Psychotic and Bipolar Disorders: Antipsychotic Drugs.

Sarah D Holder1, Alaina L Edmunds1, Sherri Morgan1.   

Abstract

Antipsychotic drugs block dopamine receptors and are used to manage psychosis as well as other mental illnesses that may or may not have psychotic features, such as bipolar disorders and major depressive disorder. First-generation antipsychotic drugs are more likely to cause adverse effects such as extrapyramidal symptoms and tardive dyskinesia. Adverse effects of second-generation antipsychotic drugs typically are related to metabolic abnormalities such as weight gain, abnormal blood glucose levels, and elevated lipid levels. Neuroleptic malignant syndrome is a rare but serious adverse effect of antipsychotic drugs that causes mental status changes, hyperthermia, and generalized rigidity. Timely diagnosis is essential due to a high risk of related morbidities if the syndrome remains untreated. Some adverse effects of antipsychotics can be identified and managed so that patients can continue beneficial therapy while minimizing the physiologic consequences. Patients taking antipsychotic drugs should be monitored regularly for adverse effects. Antipsychotics are also associated with potential drug interactions, the most lethal being prolongation of the QT interval, which can lead to fatal arrhythmias. Antipsychotic drugs can be used in special populations, such as pregnant women, children, and elderly patients, per recommendation from a mental health subspecialist. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28437058

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  4 in total

Review 1.  Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews.

Authors:  Esther Letícia Amorim Ribeiro; Tácio de Mendonça Lima; Marcio Eduardo Bergamini Vieira; Sílvia Storpirtis; Patricia Melo Aguiar
Journal:  Eur J Clin Pharmacol       Date:  2018-06-15       Impact factor: 2.953

Review 2.  Racial disparities in bipolar disorder treatment and research: a call to action.

Authors:  Margaret O Akinhanmi; Joanna M Biernacka; Stephen M Strakowski; Susan L McElroy; Joyce E Balls Berry; Kathleen R Merikangas; Shervin Assari; Melvin G McInnis; Thomas G Schulze; Marion LeBoyer; Carol Tamminga; Christi Patten; Mark A Frye
Journal:  Bipolar Disord       Date:  2018-03-12       Impact factor: 6.744

3.  Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study.

Authors:  Yirgalem Shewakena Wubeshet; Oumer Sada Mohammed; Tigestu Alemu Desse
Journal:  BMC Psychiatry       Date:  2019-01-18       Impact factor: 3.630

4.  Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden.

Authors:  Essi Heinonen; Lisa Forsberg; Ulrika Nörby; Katarina Wide; Karin Källén
Journal:  CNS Drugs       Date:  2022-02-26       Impact factor: 6.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.